This PDF is the current document as it appeared on Public Inspection on 11/06/2014 at 08:45 am.
In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee:
Times and Dates
9:00 a.m.-5:00 p.m., December 4, 2014
9:00 a.m.-12:00 p.m., December 5, 2014
Place: Emory Conference Center, The Silverbell Pavilion, 1615 Clifton Rd, Atlanta, Georgia, 30329.
Status: Open to the public, limited only by the space available. Please register for the meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions.
Matters for Discussion: The agenda will include updates on CDC's activities for prevention of healthcare associated infections (HAIs), updates on antimicrobial resistance, an update on Draft Guidelines, and updates on healthcare preparedness and emerging infections.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road NE., Mailstop A-07, Atlanta, Georgia 30333 Telephone (404) 639-4045. Email: email@example.com
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).
[FR Doc. 2014-26511 Filed 11-6-14; 8:45 am]
BILLING CODE 4163-18-P